Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurosci ; 26(18): 4729-39, 2006 May 03.
Article in English | MEDLINE | ID: mdl-16672645

ABSTRACT

The NG2 chondroitin sulfate proteoglycan inhibits axon growth in vitro. Levels of NG2 increase rapidly in the glial scars that form at sites of CNS injury, suggesting that NG2 may inhibit axon regeneration. To determine the functions of NG2, we infused mixtures of neutralizing or non-neutralizing anti-NG2 monoclonal antibodies into the dorsally transected adult rat spinal cord and analyzed the regeneration of ascending mechanosensory axons anatomically. At 1 week after injury, ascending sensory axons in control animals terminated caudal to the lesion within an area containing dense deposits of NG2 immunoreactivity. In animals treated with the neutralizing anti-NG2 antibodies, labeled axons penetrated the caudal border of the lesion and grew into and beyond the lesion center. The low intrinsic growth capacity of adult neurons may also limit the ability of damaged axons to regenerate. To enhance growth, we combined antibody treatment with a peripheral nerve conditioning lesion. After a conditioning lesion and treatment with control, non-neutralizing antibodies, many sensory axons grew into the lesion core. These axons did not grow past the rostral border of the lesion; rather, they grew along the dorsal surface of the spinal cord and within any remaining pieces of the dorsal roots. In contrast, combining a peripheral nerve conditioning lesion with neutralizing anti-NG2 antibodies resulted in sensory axon regeneration past the glial scar and into the white matter rostral to the injury site. The combinatorial approach used here that neutralizes extrinsic inhibition and increases intrinsic growth results in anatomically correct axon regeneration, a prerequisite for functional recovery.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Antigens/immunology , Axons/drug effects , Nerve Regeneration/drug effects , Neurons, Afferent/pathology , Proteoglycans/immunology , Spinal Cord Injuries/drug therapy , Analysis of Variance , Animals , Blotting, Western/methods , CD11b Antigen/metabolism , Disease Models, Animal , Ectodysplasins , Female , Fibronectins/metabolism , Fluorescent Antibody Technique/methods , Glial Fibrillary Acidic Protein/metabolism , Immunoprecipitation/methods , Laminectomy/methods , Membrane Proteins/metabolism , Myelin Proteins/metabolism , Neuroglia/drug effects , Neuroglia/pathology , Nogo Proteins , Peripheral Nervous System Diseases/drug therapy , Peripheral Nervous System Diseases/pathology , Rats , Rats, Sprague-Dawley , Spinal Cord Injuries/pathology , Time Factors , Tumor Necrosis Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...